ATNF — 180 LIFE SCIENCES ORD share price
Last Trade - 00:00- £232.92m
- £228.68m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +433.08 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News for ATNF
Upcoming events for ATNF
Similar to ATNF
180 LIFE SCIENCES ORD
NASDAQ Capital Market
9 METERS BIOPHARMA ORD
NASDAQ Capital Market
ACER THERAPEUTICS ORD
NASDAQ Capital Market
ADAGIO THERAPEUTICS ORD
NASDAQ Capital Market
ADIAL PHARMACEUTICALS ORD
NASDAQ Capital Market
ADITXT ORD
NASDAQ Capital Market
AERPIO PHARMACEUTICALS ORD
NASDAQ Capital Market
AGILE THERAPEUTICS ORD
NASDAQ Capital Market
AILERON THERAPEUTICS ORD
NASDAQ Capital Market
AKARI THERAPEUTICS ADR
NASDAQ Capital Market
ALBIREO PHARMA ORD
NASDAQ Capital Market
ALDEYRA THERAPEUTICS ORD
NASDAQ Capital Market
ALTAMIRA THERAPEUTICS ORD
NASDAQ Capital Market
ANAVEX LIFE SCIENCES ORD
NASDAQ Capital Market
APTEVO THERAPEUTICS ORD
NASDAQ Capital Market
ARIDIS PHARMACEUTICALS ORD
NASDAQ Capital Market
ARTELO BIOSCIENCES ORD
NASDAQ Capital Market
ATHERSYS ORD
NASDAQ Capital Market
AVENUE THERAPEUTICS ORD
NASDAQ Capital Market
AVEO PHARMACEUTICALS ORD
NASDAQ Capital Market
FAQ
As of Today at 16:51 UTC, shares in 180 LIFE SCIENCES ORD are trading at £7.57, giving the company a market capitalisation of £232.92m. This share price information is delayed by 15 minutes.
Shares in 180 LIFE SCIENCES ORD are currently trading at £7.57 and the price has moved by -31.18% over the past 365 days. In terms of relative price strength the 180 LIFE SCIENCES ORD share price has underperformed the S&P500 Index by -48.78% over the past year.
There is no consensus recommendation for this security.
180 LIFE SCIENCES ORD does not currently pay a dividend.
180 LIFE SCIENCES ORD does not currently pay a dividend.
180 LIFE SCIENCES ORD does not currently pay a dividend.
To buy shares in 180 LIFE SCIENCES ORD you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in 180 LIFE SCIENCES ORD are currently trading at £7.57, giving the company a market capitalisation of £232.92m.
Here are the trading details for 180 LIFE SCIENCES ORD:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: ATNF
Based on an overall assessment of its quality, value and momentum 180 LIFE SCIENCES ORD is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Relative Strength is an often used as a momentum indicator. Price trends tend to persist, so it's worth looking at them when it comes to a share like 180 LIFE SCIENCES ORD. Over the past six months, its share price has outperformed the S&P500 Index by +90.05%.
At the current price of £7.57, shares in 180 LIFE SCIENCES ORD are trading +13.98% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for 180 LIFE SCIENCES ORD.
We do not have data on 180 LIFE SCIENCES ORD's directors
We do not have data on 180 LIFE SCIENCES ORD's shareholders